Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05416203 · ClinicalTrials.gov registry record · NA

BEAST: A Pilot Trial

A NA study of Functional Impairment and Anxiety Sensitivity, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT05416203 is a NA study of Functional Impairment and Anxiety Sensitivity that has completed, run by VA Office of Research and Development. The registered enrollment target is 15 participants, below the 3,806-participant average among 3 other Functional Impairment trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05416203, a NA study of Functional Impairment and Anxiety Sensitivity, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This pilot study trial will test the acceptability, feasibility, and usability of a brief enhanced anxiety sensitivity treatment to reduce anxiety sensitivity and functional impairment in Veterans.

Interventions

  • BEHAVIORAL Brief Enhanced Anxiety Sensitivity Treatment

Study Locations (1)

New York

  • VA Finger Lakes Healthcare System, Canandaigua, NY - Canandaigua

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2022-09-01
Est. Completion 2024-08-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT05416203

The ClinicalTrials.gov registry entry for NCT05416203 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,806-participant average among 3 other Functional Impairment trials with a reported enrollment target (100% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Functional Impairment appearing as the primary indexed condition, and to 1 intervention - of which Brief Enhanced Anxiety Sensitivity Treatment is the first listed.

NCT05416203 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05416203 about?

NCT05416203 is a clinical study titled "BEAST: A Pilot Trial". This pilot study trial will test the acceptability, feasibility, and usability of a brief enhanced anxiety sensitivity treatment to reduce anxiety sensitivity and functional impairment in Veterans.

What is the current status of trial NCT05416203?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2022-09-01. Estimated completion is 2024-08-30.

What conditions does trial NCT05416203 study?

This clinical trial studies the following conditions: Functional Impairment, Anxiety Sensitivity.

What interventions are being tested in trial NCT05416203?

The interventions under investigation include: Brief Enhanced Anxiety Sensitivity Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT05416203?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05416203 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Functional Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.